+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Diagnostics Reagent Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 258 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934314
The global Molecular Diagnostics Reagent Market continues its upward trajectory, exhibiting a robust Compound Annual Growth Rate (CAGR) between 2024 and 2031. Forecasts indicate even more promising growth ahead, with an expected CAGR of 8% between 2024 and 2031.

Key Drivers of Growth:

  • Increase in Disease Prevalence: With a surge in diseases such as cancer, HIV, and others, the demand for Molecular Diagnostics Reagents has soared. These reagents play a crucial role in monitoring the efficacy of therapeutic drugs, thereby driving significant growth in the market.
  • Technological Advancements: Continuous advancements in molecular biology have revolutionized disease detection and treatment. Modern molecular diagnostics reagent technologies offer rapid and precise identification of pathogens and genetic mutations, reshaping healthcare paradigms globally. This technological evolution propels the demand for molecular diagnostics reagents, as biologists harness vast amounts of genetic data for enhanced diagnostics and treatment strategies.
  • Increase in Biomarker Development: Heightened investment in biomarker research and development amplifies the market's growth prospects. Biomarkers are increasingly utilized for disease diagnosis, prognosis, and evaluation, spurring the demand for Molecular Diagnostic Reagents. The availability of molecular diagnostic kits for infectious diseases further boosts market expansion, with major corporations actively pursuing biomarker solutions to bolster their portfolios.

Market Challenges:

Despite the optimistic growth outlook, the Molecular Diagnostics Reagent Market faces challenges, notably the "High Cost of Equipment." The substantial expense associated with molecular diagnostics devices, coupled with maintenance, licensing, and operational costs, poses a barrier to market expansion. Small medical institutions and labs with limited capital budgets may struggle to afford sophisticated analyzers, hindering widespread adoption of molecular diagnostics technologies.

Impact of COVID-19:

The COVID-19 pandemic, while detrimental to the global economy, has catalyzed growth in the Molecular Diagnostics Reagent Market. The urgent need for COVID-19 testing utilizing molecular diagnostic techniques propelled demand for diagnostic kits such as PCR and rapid antigen tests. Regulatory authorities expedited approval processes to address emergent healthcare challenges, facilitating market growth amidst the pandemic.

Competitive Analysis:

The Molecular Diagnostics Reagent industry is characterized by intense competition and consolidation among key players. However, technological innovations and product diversification enable medium and small businesses to enhance their market presence. Mergers and acquisitions are prevalent strategies among industry leaders, aimed at expanding product portfolios and market share.

Key Companies:

Leading players driving innovation and growth in the Molecular Diagnostics Reagent Market include:
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • DiaSorin S.p.A
  • Hologic Inc.
  • Other

Molecular Diagnostics Reagent Market Categorization

Molecular Diagnostics Reagent Market by Product

  • Sample Preparation Kits
  • PCR Assay Kits
  • In situ Hybridization Kits
  • Microarray Kit
  • Sequencing Kit

Molecular Diagnostics Reagent Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Molecular Diagnostics Reagent Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Molecular Diagnostics Reagent Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Molecular Diagnostics Reagent Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Molecular Diagnostics Reagent Market Outlook, 2018 - 2031
5.1. Global Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Sample Preparation Kits
5.1.1.2. PCR Assay Kits
5.1.1.3. In situ Hybridization Kits
5.1.1.4. Microarray Kit
5.1.1.5. Sequencing Kit
5.2. Global Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Pathogen Detection
5.2.1.2. Biomarker Screening
5.2.1.3. Therapeutic Monitoring
5.2.1.4. Others
5.3. Global Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Laboratories
5.3.1.3. Research Institutes
5.3.1.4. Biopharmaceutical Companies
5.3.1.5. Others
5.4. Global Molecular Diagnostics Reagent Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Molecular Diagnostics Reagent Market Outlook, 2018 - 2031
6.1. North America Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Sample Preparation Kits
6.1.1.2. PCR Assay Kits
6.1.1.3. In situ Hybridization Kits
6.1.1.4. Microarray Kit
6.1.1.5. Sequencing Kit
6.2. North America Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Pathogen Detection
6.2.1.2. Biomarker Screening
6.2.1.3. Therapeutic Monitoring
6.2.1.4. Others
6.3. North America Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Laboratories
6.3.1.3. Research Institutes
6.3.1.4. Biopharmaceutical Companies
6.3.1.5. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1.2. U.S. Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1.3. U.S. Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1.4. Canada Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1.5. Canada Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1.6. Canada Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Molecular Diagnostics Reagent Market Outlook, 2018 - 2031
7.1. Europe Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Sample Preparation Kits
7.1.1.2. PCR Assay Kits
7.1.1.3. In situ Hybridization Kits
7.1.1.4. Microarray Kit
7.1.1.5. Sequencing Kit
7.2. Europe Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Pathogen Detection
7.2.1.2. Biomarker Screening
7.2.1.3. Therapeutic Monitoring
7.2.1.4. Others
7.3. Europe Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Laboratories
7.3.1.3. Research Institutes
7.3.1.4. Biopharmaceutical Companies
7.3.1.5. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Germany Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.2. Germany Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.3. Germany Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.4. U.K. Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.5. U.K. Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.6. U.K. Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.7. France Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.8. France Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.9. France Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.10. Italy Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.11. Italy Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.12. Italy Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.13. Turkey Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.14. Turkey Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.15. Turkey Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.16. Russia Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.17. Russia Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.18. Russia Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.19. Rest of Europe Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.20. Rest of Europe Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1.21. Rest of Europe Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Molecular Diagnostics Reagent Market Outlook, 2018 - 2031
8.1. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Sample Preparation Kits
8.1.1.2. PCR Assay Kits
8.1.1.3. In situ Hybridization Kits
8.1.1.4. Microarray Kit
8.1.1.5. Sequencing Kit
8.2. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Pathogen Detection
8.2.1.2. Biomarker Screening
8.2.1.3. Therapeutic Monitoring
8.2.1.4. Others
8.3. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Laboratories
8.3.1.3. Research Institutes
8.3.1.4. Biopharmaceutical Companies
8.3.1.5. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. China Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.2. China Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.3. China Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.4. Japan Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.5. Japan Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.6. Japan Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.7. South Korea Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.8. South Korea Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.9. South Korea Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.10. India Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.11. India Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.12. India Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.13. Southeast Asia Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.14. Southeast Asia Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.15. Southeast Asia Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.16. Rest of Asia Pacific Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.17. Rest of Asia Pacific Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1.18. Rest of Asia Pacific Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Molecular Diagnostics Reagent Market Outlook, 2018 - 2031
9.1. Latin America Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Sample Preparation Kits
9.1.1.2. PCR Assay Kits
9.1.1.3. In situ Hybridization Kits
9.1.1.4. Microarray Kit
9.1.1.5. Sequencing Kit
9.2. Latin America Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Pathogen Detection
9.2.1.2. Biomarker Screening
9.2.1.3. Therapeutic Monitoring
9.2.1.4. Others
9.3. Latin America Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Laboratories
9.3.1.3. Research Institutes
9.3.1.4. Biopharmaceutical Companies
9.3.1.5. Others
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.2. Brazil Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.3. Brazil Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.4. Mexico Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.5. Mexico Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.6. Mexico Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.7. Argentina Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.8. Argentina Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.9. Argentina Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.10. Rest of Latin America Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.11. Rest of Latin America Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1.12. Rest of Latin America Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, 2018 - 2031
10.1. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Sample Preparation Kits
10.1.1.2. PCR Assay Kits
10.1.1.3. In situ Hybridization Kits
10.1.1.4. Microarray Kit
10.1.1.5. Sequencing Kit
10.2. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Pathogen Detection
10.2.1.2. Biomarker Screening
10.2.1.3. Therapeutic Monitoring
10.2.1.4. Others
10.3. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Hospitals
10.3.1.2. Laboratories
10.3.1.3. Research Institutes
10.3.1.4. Biopharmaceutical Companies
10.3.1.5. Others
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. GCC Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.2. GCC Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.3. GCC Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.4. South Africa Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.5. South Africa Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.6. South Africa Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.7. Egypt Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.8. Egypt Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.9. Egypt Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.10. Nigeria Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.11. Nigeria Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.12. Nigeria Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.13. Rest of Middle East & Africa Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.14. Rest of Middle East & Africa Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1.15. Rest of Middle East & Africa Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By Product Type vs by Application Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Becton, Dickinson and Company
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Bio-Rad Laboratories Inc
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Thermo Fisher Scientific Inc.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Merck KGaA
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Agilent Technologies, Inc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Qiagen N.V.
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Illumina, Inc.
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. DiaSorin S.p.A
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Hologic Inc.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • DiaSorin S.p.A
  • Hologic Inc.

Methodology

Loading
LOADING...